Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/bmri/volume-2015/242437/figures/242437.fig.002a.svgz" name="242437.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>TME MCT4 expression and overall survival</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/bmri/volume-2015/242437/figures/242437.fig.002b.svgz" name="242437.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Cancer cell MCT4 expression and overall survival</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/bmri/volume-2015/242437/figures/242437.fig.002c.svgz" name="242437.fig.002c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Stromal cell MCT4 expression and overall survival</td></tr></table>

<div>Elevated MCT4 expression is associated with decreased overall survival. (a) Elevated MCT4 expression in the tumor microenvironment is associated with decreased OS. (b) Elevated MCT4 expression in cancer cells is associated with decreased OS. (c) Elevated MCT4 expression in stromal cells is associated with decreased OS. SCC: squamous cell carcinoma.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis 